Lila Feisee

Array ( [id] => 3660354 [patent_doc_number] => 05591829 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-01-07 [patent_title] => 'Antibodies modified with toxic substance' [patent_app_type] => 1 [patent_app_number] => 8/410932 [patent_app_country] => US [patent_app_date] => 1995-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 11 [patent_no_of_words] => 7508 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/591/05591829.pdf [firstpage_image] =>[orig_patent_app_number] => 410932 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3690365 [patent_doc_number] => 05604117 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-02-18 [patent_title] => 'Antibodies to Plasmodium falciparum' [patent_app_type] => 1 [patent_app_number] => 8/408092 [patent_app_country] => US [patent_app_date] => 1995-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5148 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/604/05604117.pdf [firstpage_image] =>[orig_patent_app_number] => 408092 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3559259 [patent_doc_number] => 05502163 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-03-26 [patent_title] => 'Control of secretion of milk' [patent_app_type] => 1 [patent_app_number] => 8/395535 [patent_app_country] => US [patent_app_date] => 1995-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 4464 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 234 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/502/05502163.pdf [firstpage_image] =>[orig_patent_app_number] => 395535 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3652934 [patent_doc_number] => 05658570 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-08-19 [patent_title] => 'Recombinant antibodies for human therapy' [patent_app_type] => 1 [patent_app_number] => 8/379072 [patent_app_country] => US [patent_app_date] => 1995-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 15483 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/658/05658570.pdf [firstpage_image] =>[orig_patent_app_number] => 379072 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3579956 [patent_doc_number] => 05580717 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-12-03 [patent_title] => 'Recombinant library screening methods' [patent_app_type] => 1 [patent_app_number] => 8/376326 [patent_app_country] => US [patent_app_date] => 1995-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8511 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/580/05580717.pdf [firstpage_image] =>[orig_patent_app_number] => 376326 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3517055 [patent_doc_number] => 05506135 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-04-09 [patent_title] => 'Hybrid monoclonal antibodies, their production and use' [patent_app_type] => 1 [patent_app_number] => 8/366366 [patent_app_country] => US [patent_app_date] => 1994-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 20 [patent_no_of_words] => 9642 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/506/05506135.pdf [firstpage_image] =>[orig_patent_app_number] => 366366 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3617713 [patent_doc_number] => 05593675 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-01-14 [patent_title] => 'Method of producing an anti-D immunoglobulin concentrate and a pharmaceutical preparation' [patent_app_type] => 1 [patent_app_number] => 8/360334 [patent_app_country] => US [patent_app_date] => 1994-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4346 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 209 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/593/05593675.pdf [firstpage_image] =>[orig_patent_app_number] => 360334 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3531710 [patent_doc_number] => 05583202 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-12-10 [patent_title] => 'Antigenized antibodies and genes' [patent_app_type] => 1 [patent_app_number] => 8/357452 [patent_app_country] => US [patent_app_date] => 1994-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 7 [patent_no_of_words] => 6760 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/583/05583202.pdf [firstpage_image] =>[orig_patent_app_number] => 357452 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3496135 [patent_doc_number] => 05508386 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-04-16 [patent_title] => 'Antigenized antibodies and genes' [patent_app_type] => 1 [patent_app_number] => 8/357495 [patent_app_country] => US [patent_app_date] => 1994-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 7 [patent_no_of_words] => 6779 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/508/05508386.pdf [firstpage_image] =>[orig_patent_app_number] => 357495 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3659023 [patent_doc_number] => 05656435 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-08-12 [patent_title] => 'Antibodies to peptides having NGF-like activity, said antibodies having no substantial cross-reactivity with NGF, and use thereof' [patent_app_type] => 1 [patent_app_number] => 8/350214 [patent_app_country] => US [patent_app_date] => 1994-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 15 [patent_no_of_words] => 15666 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/656/05656435.pdf [firstpage_image] =>[orig_patent_app_number] => 350214 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3859848 [patent_doc_number] => 05795752 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-08-18 [patent_title] => 'Method for creating superinduced cDNA library & isolating ligand-stimulated genes' [patent_app_type] => 1 [patent_app_number] => 8/330108 [patent_app_country] => US [patent_app_date] => 1994-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8598 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/795/05795752.pdf [firstpage_image] =>[orig_patent_app_number] => 330108 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3660334 [patent_doc_number] => 05591828 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-01-07 [patent_title] => 'Bispecific and oligospecific mono-and oligovalent receptors, the preparation and use thereof' [patent_app_type] => 1 [patent_app_number] => 8/317612 [patent_app_country] => US [patent_app_date] => 1994-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 25 [patent_no_of_words] => 7414 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 103 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/591/05591828.pdf [firstpage_image] =>[orig_patent_app_number] => 317612 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3678714 [patent_doc_number] => 05632990 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-05-27 [patent_title] => 'Treatment for tumors comprising conjugated antibody A5B7 and a prodrug' [patent_app_type] => 1 [patent_app_number] => 8/313866 [patent_app_country] => US [patent_app_date] => 1994-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 6 [patent_no_of_words] => 6541 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/632/05632990.pdf [firstpage_image] =>[orig_patent_app_number] => 313866 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4006158 [patent_doc_number] => 05859205 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-12 [patent_title] => 'Humanised antibodies' [patent_app_type] => 1 [patent_app_number] => 8/303569 [patent_app_country] => US [patent_app_date] => 1994-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 19 [patent_no_of_words] => 18374 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 132 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/859/05859205.pdf [firstpage_image] =>[orig_patent_app_number] => 303569 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3521576 [patent_doc_number] => 05503833 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-04-02 [patent_title] => 'VP6 encapsulated drug delivery' [patent_app_type] => 1 [patent_app_number] => 8/301267 [patent_app_country] => US [patent_app_date] => 1994-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10132 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/503/05503833.pdf [firstpage_image] =>[orig_patent_app_number] => 301267 [rel_patent_id] =>[rel_patent_doc_number] =>)